Financials Xylem Inc.

Equities

XYL

US98419M1009

Industrial Machinery & Equipment

Market Closed - Nyse 04:00:02 2024-05-24 pm EDT 5-day change 1st Jan Change
144.2 USD +0.37% Intraday chart for Xylem Inc. +0.65% +26.14%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 14,188 18,346 21,625 19,927 27,570 34,973 - -
Enterprise Value (EV) 1 15,780 19,555 22,716 20,863 28,835 35,632 34,950 34,052
P/E ratio 35.7 x 72.7 x 51 x 56.4 x 41 x 43.1 x 36.1 x 31.1 x
Yield 1.22% 1.02% 0.93% 1.09% 1.15% 1% 1.07% 1.11%
Capitalization / Revenue 2.7 x 3.76 x 4.16 x 3.61 x 3.74 x 4.08 x 3.88 x 3.67 x
EV / Revenue 3.01 x 4.01 x 4.37 x 3.78 x 3.92 x 4.16 x 3.87 x 3.57 x
EV / EBITDA 16 x 25.2 x 26.5 x 23 x 20.7 x 20.5 x 18.5 x 16.5 x
EV / FCF 25.7 x 30.5 x 68.8 x 53.8 x 48.1 x 35.8 x 31.1 x 27.6 x
FCF Yield 3.88% 3.28% 1.45% 1.86% 2.08% 2.79% 3.21% 3.62%
Price to Book 4.8 x 6.19 x 6.72 x 5.7 x 2.72 x 3.27 x 3.08 x 2.88 x
Nbr of stocks (in thousands) 180,079 180,232 180,325 180,222 241,078 242,447 - -
Reference price 2 78.79 101.8 119.9 110.6 114.4 144.2 144.2 144.2
Announcement Date 2/6/20 2/4/21 2/3/22 2/7/23 2/6/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 5,249 4,876 5,195 5,522 7,364 8,563 9,019 9,535
EBITDA 1 984 776 856 908 1,392 1,740 1,893 2,067
EBIT 1 727 525 611 672 1,072 1,364 1,530 1,681
Operating Margin 13.85% 10.77% 11.76% 12.17% 14.56% 15.93% 16.96% 17.63%
Earnings before Tax (EBT) 1 416 285 511 440 635 1,013 1,230 1,387
Net income 1 401 254 427 355 609 827.4 992.7 1,114
Net margin 7.64% 5.21% 8.22% 6.43% 8.27% 9.66% 11.01% 11.69%
EPS 2 2.210 1.400 2.350 1.960 2.790 3.343 3.993 4.635
Free Cash Flow 1 613 641 330 388 599 995.6 1,123 1,232
FCF margin 11.68% 13.15% 6.35% 7.03% 8.13% 11.63% 12.45% 12.93%
FCF Conversion (EBITDA) 62.3% 82.6% 38.55% 42.73% 43.03% 57.22% 59.32% 59.62%
FCF Conversion (Net income) 152.87% 252.36% 77.28% 109.3% 98.36% 120.33% 113.15% 110.61%
Dividend per Share 2 0.9600 1.040 1.120 1.200 1.320 1.441 1.540 1.600
Announcement Date 2/6/20 2/4/21 2/3/22 2/7/23 2/6/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 1,323 1,272 1,364 1,380 1,506 1,448 1,722 2,076 2,118 2,033 2,143 2,177 2,215 2,130 2,249
EBITDA 1 206 174 215 245 274 236 329 411 416 391 435.3 453.2 465.4 623 491.7
EBIT 1 147 116 155 187 214 167 259 315 313 294 340.7 359.8 371.1 336.1 397.2
Operating Margin 11.11% 9.12% 11.36% 13.55% 14.21% 11.53% 15.04% 15.17% 14.78% 14.46% 15.9% 16.53% 16.75% 15.78% 17.67%
Earnings before Tax (EBT) 1 126 98 136 17 189 126 114 185 210 196 249.8 264 287.6 - -
Net income 1 113 82 112 12 149 99 92 152 266 153 214.2 229.8 239.7 203.1 243.5
Net margin 8.54% 6.45% 8.21% 0.87% 9.89% 6.84% 5.34% 7.32% 12.56% 7.53% 10% 10.55% 10.82% 9.54% 10.83%
EPS 2 0.6200 0.4500 0.6200 0.0700 0.8200 0.5400 0.4500 0.6300 1.100 0.6300 0.8729 0.9089 0.9619 0.8098 0.9764
Dividend per Share 2 0.2800 0.3000 0.3000 0.3000 0.3000 0.3300 0.3300 - 0.3300 - 0.3600 0.3600 0.3600 0.3600 -
Announcement Date 2/3/22 5/4/22 8/2/22 11/1/22 2/7/23 5/4/23 8/2/23 10/31/23 2/6/24 5/2/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,592 1,209 1,091 936 1,265 659 - -
Net Cash position 1 - - - - - - 23.2 921
Leverage (Debt/EBITDA) 1.618 x 1.558 x 1.275 x 1.031 x 0.9088 x 0.3788 x - -
Free Cash Flow 1 613 641 330 388 599 996 1,123 1,232
ROE (net income / shareholders' equity) 19.1% 8.57% 13.8% 15.4% 12.1% 9.28% 10% 10.4%
ROA (Net income/ Total Assets) 7.33% 3.09% 5.02% 4.38% 5.06% 4.84% 5.93% 6.49%
Assets 1 5,473 8,230 8,513 8,114 12,032 17,088 16,750 17,166
Book Value Per Share 2 16.40 16.50 17.80 19.40 42.10 44.10 46.80 50.00
Cash Flow per Share 2 4.630 4.550 2.960 3.290 3.840 5.720 6.550 7.300
Capex 1 226 183 208 208 271 388 403 431
Capex / Sales 4.31% 3.75% 4% 3.77% 3.68% 4.53% 4.47% 4.52%
Announcement Date 2/6/20 2/4/21 2/3/22 2/7/23 2/6/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
144.2 USD
Average target price
143.6 USD
Spread / Average Target
-0.43%
Consensus
  1. Stock Market
  2. Equities
  3. XYL Stock
  4. Financials Xylem Inc.